By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Puma Biotechnology 

10940 Wilshire Boulevard
Suite 600
Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


SEARCH JOBS








Company News
Puma Biotech (PBYI)’s ExteNET Phase III Study Published Online In The Lancet Oncology 2/11/2016 10:15:00 AM
Puma Biotech (PBYI) To Participate In Fireside Chat At Leerink Partners Global Healthcare Conference 2/3/2016 11:35:10 AM
Puma Biotech (PBYI) Shareholders Overwhelmingly Reject Eshelman’s Consent Solicitation 1/8/2016 8:13:51 AM
Puma Biotech (PBYI) To Present At J.P. Morgan Healthcare Conference 1/5/2016 10:47:04 AM
Third Independent Proxy Advisory Firm Recommends That Puma Biotech (PBYI) Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card 12/30/2015 9:28:19 AM
Second Leading Independent Proxy Advisory Firm Recommends That Puma Biotech (PBYI) Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card 12/29/2015 8:48:35 AM
ISS Recommends That Puma Biotech (PBYI) Shareholders Reject Eshelman's Consent Solicitation By REVOKING CONSENT On Puma's BLUE Consent Revocation Card 12/23/2015 10:56:55 AM
Puma Biotech (PBYI) Expands Third Cohort In Phase II Trial Of PB272 In HER2 Mutation Positive Cancer Patients 12/18/2015 11:08:52 AM
Puma Biotech (PBYI) To Host Conference Call To Discuss Loperamide Prophylaxis To Reduce Neratinib-Related Diarrhea 12/17/2015 9:51:40 AM
Puma Biotech (PBYI) Presents 3-Year Disease Free Survival Data From Phase III Trial Of PB272 In Extended Adjuvant Breast Cancer (Extenet Trial) At The 2015 San Antonio Breast Cancer Symposium 12/11/2015 10:36:21 AM
12345678910...
//-->